Suppr超能文献

持续输注氯普鲁卡因用于新生儿、婴儿和儿童胸段及骶管硬膜外术后镇痛。

Continuous chloroprocaine infusion for thoracic and caudal epidurals as a postoperative analgesia modality in neonates, infants, and children.

作者信息

Veneziano Giorgio, Iliev Peter, Tripi Jennifer, Martin David, Aldrink Jennifer, Bhalla Tarun, Tobias Joseph

机构信息

Department of Anesthesiology & Pain Medicine, Nationwide Children's Hospital, Columbus, OH, USA.

Department of Anesthesiology & Pain Medicine, The Ohio State University College of Medicine, Columbus, OH, USA.

出版信息

Paediatr Anaesth. 2016 Jan;26(1):84-91. doi: 10.1111/pan.12807. Epub 2015 Nov 4.

Abstract

BACKGROUND

Neonates and infants have decreased metabolic capacity for amide local anesthetics and increased risk of local anesthetic toxicity compared to the general population. Chloroprocaine is an ester local anesthetic that has an extremely short plasma half-life in infants as well as adults. Existing reports support the safety and efficacy of continuous chloroprocaine epidural infusions in neonates and young infants during the intraoperative period. Despite this, continuous chloroprocaine epidural infusion may be an under-utilized method of postoperative analgesia for this patient population. In particular, it may improve pain control in neonates and infants with incisions stretching many dermatomes or those with hepatic impairment.

METHODS

We retrospectively reviewed our experience over 4 years with continuous chloroprocaine epidural infusions in neonates, infants, and children with a focus on the postoperative management of pain.

RESULTS

Twenty-one pediatric patients received continuous 2-chloroprocaine epidural infusions for postoperative pain management from January 2010 to April 2014 for thoracic, abdominal, and limb procedures. The epidural infusion consisted of 1.5% chloroprocaine or 1.5% chloroprocaine with fentanyl. Tabulating the morphine and hydromorphone used for rescue analgesia, the median (interquartile range) opioid consumption (mg·kg(-1) ·day(-1) of intravenous morphine equivalents) for the first, second, and third 24-h postoperative periods were 0.02 (0-0.48), 0.30 (0-0.44), and 0.14 (0-0.29), respectively. Examining the total fentanyl usage, the median (interquartile range) fentanyl consumption (μg·kg(-1) ·day(-1)) for first, second, and third 24-h postoperative periods were 3.89 (0.41-7.24), 0 (0.00-4.06), and 0 (0.00-0.51), respectively. The median N-PASS score assessed every 6 h from 0 to 72 h postoperatively was 0, 1, 2, 0, 0, 1, 0, 0, 0, 0, 1, 0, and 0, respectively. The median FLACC score assessed every 6 h from 0 to 72 h postoperatively was 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, and 0, respectively.

CONCLUSION

The results suggest that chloroprocaine offers an efficacious alternative to the amide local anesthetics for postoperative epidural analgesia in the pediatric population.

摘要

背景

与普通人群相比,新生儿和婴儿对酰胺类局部麻醉药的代谢能力降低,发生局部麻醉药毒性的风险增加。氯普鲁卡因是一种酯类局部麻醉药,在婴儿和成人中血浆半衰期极短。现有报告支持在术中对新生儿和幼儿持续硬膜外输注氯普鲁卡因的安全性和有效性。尽管如此,持续硬膜外输注氯普鲁卡因可能是该患者群体术后镇痛未得到充分利用的方法。特别是,它可能改善切口跨越多个皮节的新生儿和婴儿或肝功能损害患儿的疼痛控制。

方法

我们回顾性分析了4年来在新生儿、婴儿和儿童中持续硬膜外输注氯普鲁卡因的经验,重点是术后疼痛管理。

结果

2010年1月至2014年4月,21例儿科患者接受了持续2-氯普鲁卡因硬膜外输注以进行术后疼痛管理,手术涉及胸部、腹部和四肢。硬膜外输注液为1.5%氯普鲁卡因或1.5%氯普鲁卡因加芬太尼。统计用于补救镇痛的吗啡和氢吗啡酮用量,术后第1个、第2个和第3个24小时期间静脉注射吗啡等效物的中位(四分位间距)阿片类药物消耗量(mg·kg⁻¹·天⁻¹)分别为0.02(0 - 0.48)、0.30(0 - 0.44)和0.14(0 - 0.29)。查看芬太尼总用量,术后第1个、第2个和第3个24小时期间的中位(四分位间距)芬太尼消耗量(μg·kg⁻¹·天⁻¹)分别为3.89(0.41 - 7.24)、0(0.00 - 4.06)和0(0.00 - 0.51)。术后0至72小时每6小时评估一次的中位N - PASS评分分别为0、1、2、0、0、1、0、0、0、0、1、0和0。术后0至72小时每6小时评估一次的中位FLACC评分分别为0、0、2、0、0、0、0、0、0、0、0、0和0。

结论

结果表明,对于儿科人群术后硬膜外镇痛,氯普鲁卡因是酰胺类局部麻醉药的有效替代药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验